EMEA-001065-PIP01-10

Key facts

Invented name
Angiox
Active substance
Bivalirudin
Therapeutic area
Cardiovascular diseases
Decision number
P/0110/2012
PIP number
EMEA-001065-PIP01-10
Pharmaceutical form(s)
Powder for concentrate for solution for infusion
Condition(s) / indication(s)
  • Treatment of atherosclerosis
  • Treatment of thrombosis
Route(s) of administration
Intravenous use
Contact for public enquiries
The Medicines Company UK Limited
United Kingdom
camille.debray@themedco.com 
+44 1235 448500
+44 1235 835561
Decision type
RP: decision refers to a refusal on a proposed Paediatric Investigation Plan

Decision

How useful was this page?

Add your rating